Trial Profile
A study evaluating effect of cenicriviroc on central nervous system in HIV infected patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2017
Price :
$35
*
At a glance
- Drugs Cenicriviroc (Primary)
- Indications Cognition disorders; HIV infections
- Focus Pharmacodynamics; Therapeutic Use
- 28 Mar 2017 New trial record
- 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections